Arrivo BioVentures
Working in partnership with investors, innovators, and pharmaceutical companies, Arrivo is always seeking solutions for unmet medical needs. Arrivo strives to set a new standard that starts with the selection of drug candidates through clinical development. Arrivo has built a portfolio of diverse drug candidates with the potential to be first-in-class or best-in-class. It is not just the products that are novel. Arrivo's entire approach is novel. The company's unique form of drug development has resulted in a history of product successes and excellent returns. The company stands on a solid foundation as the team has an average of more than 25 years of experience in drug development. Arrivo is founded and led by a team that has built and sold four companies in the last 15 years. Two products are currently commercially available and helping patients. Arrivo is propelled forward by its insatiable curiosity and drive to solve complex problems and help millions of patients globally. Arrivo is based in Morrisville, N.C., on the edge of Research Triangle Park.
About Arrivo BioVentures
Founded
2015Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$94MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
3254Location
City
MorrisvilleState
North CarolinaCountry
United StatesArrivo BioVentures
Find your buyer within Arrivo BioVentures